Chia Lin Wang

Chia Lin Wang

Director/Board Member at JHL BIOTECH, INC.

Health Technology
Consumer Services
Process Industries

Profile

Chia Lin Wang is currently the CEO-Development Centre at DuPont Taiwan Ltd.
and the Chief Executive Officer at Biogate Medical Science Corp.
He also holds independent director positions at Eden Biologics, Inc., Foresee Pharmaceuticals Co., Ltd., Unipharma Co., Ltd., and Luminescence Technology Corp.
He previously held the position of CEO-Development Centre at Merck & Co., Inc. and Chief Executive Officer at Development Center for Biotechnology.
Dr. Wang holds a doctorate from the University of Pittsburgh and an undergraduate degree from National Taiwan University.

Chia Lin Wang active positions

CompaniesPositionStart
JHL BIOTECH, INC. Director/Board Member 2015-05-13
UNIPHARMA CO., LTD. Director/Board Member 2017-06-26
FORESEE PHARMACEUTICALS CO., LTD. Director/Board Member 2016-03-30
LUMINESCENCE TECHNOLOGY CORP. Director/Board Member 2019-05-23
Biogate Medical Science Corp. Chief Executive Officer -
Corporate Officer/Principal -
All active positions of Chia Lin Wang

Former positions of Chia Lin Wang

CompaniesPositionEnd
Chief Executive Officer -
MERCK & CO., INC. Corporate Officer/Principal -
See the detail of Chia Lin Wang's experience

Training of Chia Lin Wang

University of Pittsburgh Doctorate Degree
National Taiwan University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chia Lin Wang's experience

Connections

59

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
MERCK & CO., INC.

Health Technology

FORESEE PHARMACEUTICALS CO., LTD.

Health Technology

UNIPHARMA CO., LTD.

Distribution Services

LUMINESCENCE TECHNOLOGY CORP.

Process Industries

Private companies4

Health Services

Process Industries

Health Technology

Biogate Medical Science Corp.

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW